(Q83978369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Long-term follow-up of different refractory systemic vasculitides treated with rituximab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Systemic vasculitides

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Frances Rees

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ramin Yazdani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

27 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1241-1245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

29 January 2020

cites work

1 reference

12 December 2020

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

1 reference

12 December 2020

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

1 reference

12 December 2020

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

1 reference

12 December 2020

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

12 December 2020

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

1 reference

12 December 2020

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab

1 reference

12 December 2020

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients

1 reference

12 December 2020

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab

1 reference

12 December 2020

Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations

1 reference

12 December 2020

Two cases of refractory Wegener's granulomatosis successfully treated with rituximab

1 reference

12 December 2020

Development of comprehensive disease assessment in systemic vasculitis

1 reference

12 December 2020

Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis

1 reference

12 December 2020

B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study

1 reference

12 December 2020

10.1007/S10067-011-1756-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523362%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference